Schattenberg, Joern M.
Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefitGUT. Bd. 69. H. 8. 2020 S. 1377-1378
Schattenberg, Joern M.
Prof Jorn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH)EXPERT OPINION ON INVESTIGATIONAL DRUGS. Bd. 29. H. 2. 2020 S. 111-113
Watzka, F. M.; Meyer, F.; Staubitz, J. I. et al.
Prognostic Assessment of Non-functioning Neuroendocrine Pancreatic Neoplasms as a Basis for Risk-Adapted Resection Strategies (vol 44, pg 594, 2020)WORLD JOURNAL OF SURGERY. Bd. 44. H. 5. 2020 S. 1681-1681
Hacker, Ulrich T.; Hasenclever, Dirk; Linder, Nicolas et al.
Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trialJOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE. Bd. 11. H. 1. 2020 S. 135-144
Oba, Koji; Paoletto, Xavier; Bang, Yung-Jue et al.
Progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in advanced/recurrent gastric cancer (AGC) treatment: Individual-patient-data (IPD) based meta-analysis of randomized trials.JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020
Labenz, Christian; Kostev, Karel; Galle, Peter R. et al.
Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosisMEDICINE. Bd. 99. H. 50. 2020
Labenz, Christian; Woerns, Marcus-Alexander; Adarkwah, Charles C. et al.
Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based studyALIMENTARY PHARMACOLOGY & THERAPEUTICS. Bd. 52. H. 6. 2020 S. 1042-1050
Rades, Dirk; Bartscht, Tobias; Hunold, Peter et al.
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. 9. 2020 S. 795-804
Kudo, Masatoshi; Galle, Peter R.; Llovet, Josep M. et al.
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2LIVER INTERNATIONAL. Bd. 40. H. 8. 2020 S. 2008-2020
Zhu, Andrew X.; Ikeda, Masafumi; Galle, Peter R. et al.
Ramucirumab in patients with advanced HCC and elevated alpha-fetoprotein (AFP): Outcomes by treatment-emergent ascites.JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020